secwatch.observer — SEC 8-K summary
======================================

Issuer:     STAAR SURGICAL CO (STAA)
CIK:        0000718937
Form:       8-K
Filed at:   2026-08-06T15:04:58+00:00
Accession:  0001193125-26-337197
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

STAAR Surgical appoints Warren Foust as President and CEO, Deborah Andrews as EVP/CFO
--------------------------------------------------------------------------------

- Warren Foust appointed President and CEO and Board member effective August 4, 2026; previously COO and Interim Co-CEO.
- Deborah Andrews appointed EVP, continues as CFO; she served as Interim Co-CEO since February 2026.
- Foust receives $730k base salary, 100% target bonus, and equity grants including performance options with $50/$75/$100 stock price hurdles.
- Foust joined STAAR in April 2023; prior role was Worldwide President at Johnson & Johnson Vision Surgical.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/0001193125-26-337197-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/718937/000119312526337197/staa-20260805.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-337197

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer